Reducing the global breast cancer burden: the importance of patterns of care research.
暂无分享,去创建一个
J. Bergh | M. Piccart | G. Hortobagyi | W. Eiermann | M. Aapro | K. Albain | M. Caleffi | M. Pegram | M. Toi | R. Coleman | R. Snyder | T. Pieńkowski | F. Içli | J. de la Garza Salazar
[1] M. Clarke. Ovarian ablation for early breast cancer. , 2008, The Cochrane database of systematic reviews.
[2] M. Rivard,et al. Compliance with consensus recommendations for systemic therapy is associated with improved survival of women with node-negative breast cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] R. Silliman. Crossing the quality chasm in breast cancer care. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] C. Gillis,et al. Why does specialist treatment of breast cancer improve survival? The role of surgical management , 2004, British Journal of Cancer.
[5] H. D. de Koning,et al. Trends in the usage of adjuvant systemic therapy for breast cancer in the Netherlands and its effect on mortality , 2004, British Journal of Cancer.
[6] Ahmedin Jemal,et al. Cancer Disparities by Race/Ethnicity and Socioeconomic Status , 2004, CA: a cancer journal for clinicians.
[7] B. Bloom,et al. Breast cancer treatment in clinical practice compared to best evidence and practice guidelines , 2004, British Journal of Cancer.
[8] L. Richardson. Treatment of Breast Cancer in Medically Underserved Women: A Review , 2004, The breast journal.
[9] Ahmedin Jemal,et al. Trends in Breast Cancer by Race and Ethnicity , 2003, CA: a cancer journal for clinicians.
[10] M. Coleman,et al. Stage at diagnosis is a key explanation of differences in breast cancer survival across Europe , 2003, International journal of cancer.
[11] R. Gelber,et al. Systemic treatments for women with breast cancer: outcome with relation to screening for the disease. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[12] F. Bray,et al. Breast cancer incidence and mortality trends in 16 European countries. , 2003, European journal of cancer.
[13] A. Goldhirsch,et al. Adjuvant systemic therapies in women with breast cancer: an audit of clinical practice in Italy. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.
[14] A. DeMichele,et al. Older age predicts a decline in adjuvant chemotherapy recommendations for patients with breast carcinoma , 2003, Cancer.
[15] L. Tabár,et al. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening , 2003, The Lancet.
[16] N. Bickell,et al. Physicians’ Reasons for Failing to Deliver Effective Breast Cancer Care: A Framework for Underuse , 2003, Medical care.
[17] T. Pajak,et al. Compliance with breast‐conservation standards for patients with early‐stage breast carcinoma , 2003, Cancer.
[18] Xianglin L. Du,et al. Discrepancy between Consensus Recommendations and Actual Community Use of Adjuvant Chemotherapy in Women with Breast Cancer , 2003, Annals of Internal Medicine.
[19] E. Feuer,et al. Trends in use of adjuvant multi-agent chemotherapy and tamoxifen for breast cancer in the United States: 1975-1999. , 2002, Journal of the National Cancer Institute.
[20] R. Brook,et al. Quality of breast cancer care: what do we know? , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[21] K. Kahn,et al. The case identification challenge in measuring quality of cancer care. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] G. Parrinello,et al. Are International Guidelines for the Prescription of Adjuvant Treatment for Early Breast Cancer Followed in Clinical Practice? Results of a Population-Based Study on 1547 Patients , 2002, Tumori.
[23] Sue A Joslyn,et al. Racial differences in treatment and survival from early‐stage breast carcinoma , 2002, Cancer.
[24] Beth A Virnig,et al. Utility of the SEER-Medicare Data to Identify Chemotherapy Use , 2002, Medical care.
[25] K. Kahn,et al. Developing a Reliable, Valid, and Feasible Plan for Quality-of-Care Measurement for Cancer: How Should We Measure? , 2002, Medical care.
[26] Colin B Begg,et al. Survival of blacks and whites after a cancer diagnosis. , 2002, JAMA.
[27] Cathy J Bradley,et al. Race, socioeconomic status, and breast cancer treatment and survival. , 2002, Journal of the National Cancer Institute.
[28] L. Clegg,et al. Adjuvant therapy for breast cancer: practice patterns of community physicians. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] Ingvar Andersson,et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials , 2002, The Lancet.
[30] V. Shavers,et al. Racial and ethnic disparities in the receipt of cancer treatment. , 2002, Journal of the National Cancer Institute.
[31] R. Gelber,et al. Meeting highlights: international consensus panel on the treatment of primary breast cancer. , 2002, Journal of the National Cancer Institute.
[32] D. Miles,et al. Variations in treatment and survival in breast cancer. , 2001, The Lancet. Oncology.
[33] Jeffrey N. Jonkman,et al. Identifying a Cohort of Patients With Early-Stage Breast Cancer: A Comparison of Hospital Discharge and Primary Data , 2001, Medical care.
[34] M. Sant. Differences in stage and therapy for breast cancer across Europe , 2001, International journal of cancer.
[35] R. Gelber,et al. Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer. Seventh International Conference on Adjuvant Therapy of Primary Breast Cancer. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[36] G. Budd,et al. Delivering adjuvant chemotherapy to women with early‐stage breast carcinoma , 2001, Cancer.
[37] J F Wilson,et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[38] J. Goodwin,et al. Patterns of use of chemotherapy for breast cancer in older women: findings from Medicare claims data. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[39] T. Key,et al. Epidemiology of breast cancer. , 2001, The Lancet. Oncology.
[40] M. Chassin,et al. The Quality of Early-Stage Breast Cancer Care , 2000, Annals of surgery.
[41] J. Brisson,et al. Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. , 1999, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[42] E. White,et al. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma , 1999, Cancer.
[43] J. Brisson,et al. Time trends in systemic adjuvant treatment for node-negative breast cancer. , 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[44] J. Brisson,et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women , 1999, Cancer.
[45] F. Berrino,et al. Variations in survival from breast cancer in Europe by age and country, 1978-1989. EUROCARE Working Group. , 1998, European journal of cancer.
[46] Daniel S. Miller,et al. Cancer surveillance in the U.S. , 1998, Cancer.
[47] F. Berrino,et al. Survival of women with breast cancer in Europe: Variation with age, year of diagnosis and country , 1998, International journal of cancer.
[48] J. Gurwitz,et al. The quality of care for treatment of early stage breast carcinoma , 1998, Cancer.
[49] M S Swanson,et al. Influence of socioeconomic and cultural factors on racial differences in late-stage presentation of breast cancer. , 1998, JAMA.
[50] S. Coughlin,et al. Mammography Use Helps To Explain Differences in Breast Cancer Stage at Diagnosis between Older Black and White Women , 1998, Annals of Internal Medicine.
[51] A. Taylor-Vaisey,et al. Translating guidelines into practice. A systematic review of theoretic concepts, practical experience and research evidence in the adoption of clinical practice guidelines. , 1997, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.
[52] M. Schapira,et al. Generalizability of the surveillance, epidemiology, and end results registry population: factors relevant to epidemiologic and health care research. , 1997, Journal of clinical epidemiology.
[53] C. Redmond,et al. Prognosis among African‐American women and white women with lymph node negative breast carcinoma , 1997, Cancer.
[54] R. Weichselbaum,et al. Race and clinical outcome in breast cancer in a series with long-term follow-up evaluation. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[55] P. Craft,et al. Surgical management of breast cancer in Australian women in 1993: analysis of Medicare statistics , 1997, The Medical journal of Australia.
[56] K C Carriere,et al. Information needs and decisional preferences in women with breast cancer. , 1997, JAMA.
[57] S. Martino,et al. Influence of patient characteristics, socioeconomic factors, geography, and systemic risk on the use of breast-sparing treatment in women enrolled in adjuvant breast cancer studies: an analysis of two intergroup trials. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[58] L. Kessler,et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. , 1996, Journal of the National Cancer Institute.
[59] B. Hankey,et al. Completeness of hospital cancer case reporting from the SEER program of the national cancer institute , 1995 .
[60] C. Round,et al. Influence of clinician workload and patterns of treatment on survival from breast cancer , 1995, The Lancet.
[61] S. Joslyn. Racial differences in survival from breast cancer. , 1995, JAMA.
[62] C K Redmond,et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. , 1994, JAMA.
[63] G. Giles,et al. Changes in the investigation and management of primary operable breast cancer in Victoria , 1994, The Medical journal of Australia.
[64] A. Kaluzny,et al. Physician and Practice Characteristics Associated With Judgments About Breast Cancer Treatment , 1994, Medical care.
[65] B. Kohler,et al. The Relation between Health Insurance Coverage and Clinical Outcomes among Women with Breast Cancer , 1993 .
[66] A B Nattinger,et al. Geographic variation in the use of breast-conserving treatment for breast cancer. , 1992, The New England journal of medicine.
[67] J. Samet,et al. Geographic variation in the treatment of localized breast cancer. , 1992, The New England journal of medicine.
[68] J. Strain,et al. Predictors of physician nonadherence to chemotherapy regimens , 1991, Cancer.
[69] D. Kanouse,et al. Changing practice patterns in the management of primary breast cancer: Consensus Development Program. , 1990, Health services research.
[70] B. McNeil,et al. Determinants of Physicians’ Preferences for Alternative Treatments in Women with Early Breast Cancer , 1987, Tumori.
[71] Thomas J. Smith,et al. Variation in staging and treatment of local and regional breast cancer in the elderly , 2005, Breast Cancer Research and Treatment.
[72] P. Ravdin,et al. Decision-making in early breast cancer: guidelines and decision tools. , 2002, European journal of cancer.
[73] Joseph V. Simone,et al. Ensuring Quality Cancer Care , 1999 .
[74] V. Goel,et al. Compliance with practice guidelines for node-negative breast cancer. , 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[75] Assurance in Medicare,et al. Medicare: A Strategy for Quality Assurance: VOLUME II Sources and Methods , 1990 .